Shalby

₹269.1 -0.8 | 0.3%

WEBSITE BSE:540797 NSE : SHALBY 10 May, 16:01

Market Cap ₹2907 Cr.

Stock P/E 35.5

P/B 3

Current Price ₹269.1

Book Value ₹ 91.1

Face Value 10

52W High ₹333.9

Dividend Yield 0.45%

52W Low ₹ 134.8

Edit Ratio

Shalby Research see more...

Overview Inc. Year: 2004Industry: Hospital & Healthcare Services

Shalby Ltd operates a multi-speciality chain of hospitals. Its hospitals are tertiary care hospitals, which give quaternary healthcare services. It provides offerings to a range of specialization, together with orthopaedics, joint replacements, cardiology, neurology, oncology, and renal transplantations. The Company specializes in cognizance on Tier-I and Tier-II cities. Its hospitals operate across 5 states. Its outpatient clinic operates throughout 53 cities in 16 states in India, and Shalby Arthroplasty Centre of Excellence (SACE) in five cities in four states in India. The Company’s global footprint consists of six outpatient clinics and one SACE in Africa, and two SACE in the United Arab Emirates. It affords inpatient and outpatient consultative offerings through eleven hospitals, having a combination operational mattress capability of approximately2,012 beds. It additionally gives outpatient services thru about 68 clinics and eight shared surgery centres within third party hospitals.

Shalby Share Price

New

Volume

Price

Price: NSE50 DMA200 DMAVolume

Quarterly Price

Quarterly Monthly

Show Value Show %

Peer Comparison

Shalby Quarterly Results

#(Fig in Cr.)	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Net Sales	182	162	163	202	202	202	199	235	238	216
Other Income	3	3	4	4	5	4	9	5	5	5
Total Income	184	165	167	206	207	207	208	240	243	221
Total Expenditure	152	134	139	162	165	169	173	192	185	174
Operating Profit	32	31	28	44	42	38	35	48	58	47
Interest	2	2	2	2	2	3	3	3	3	4
Depreciation	11	11	11	12	12	12	13	12	12	12
Exceptional Income / Expenses	0	-4	0	0	0	0	0	0	0	0
Profit Before Tax	19	14	15	31	29	24	19	33	43	31
Provision for Tax	8	1	5	11	10	8	5	12	15	12
Profit After Tax	11	13	10	20	18	15	14	21	28	19
Adjustments	0	0	0	0	0	0	0	0	0	0
Profit After Adjustments	11	13	10	20	18	15	14	21	28	19
Adjusted Earnings Per Share	1	1.2	0.9	1.9	1.7	1.4	1.3	1.9	2.6	1.8

Shalby Profit & Loss

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	TTM
Net Sales	225	259	275	290	324	378	462	487	431	699	805	888
Other Income	5	3	2	2	7	10	9	17	9	12	23	24
Total Income	230	262	278	293	331	388	472	504	440	711	827	912
Total Expenditure	183	196	208	235	252	299	379	404	344	577	667	724
Operating Profit	46	66	70	58	78	89	93	100	96	134	161	188
Interest	0	2	5	10	11	12	9	7	5	8	11	13
Depreciation	27	11	21	11	17	23	33	36	37	43	48	49
Exceptional Income / Expenses	0	0	0	0	0	0	0	0	0	-4	0	0
Profit Before Tax	19	52	43	36	50	54	50	57	55	79	102	126
Provision for Tax	4	14	18	-0	22	15	19	29	13	25	34	44
Profit After Tax	15	38	25	36	29	39	32	28	42	54	68	82
Adjustments	2	1	1	1	1	0	0	0	0	0	0	0
Profit After Adjustments	17	39	26	38	30	39	32	28	42	54	68	82
Adjusted Earnings Per Share	0	0	0	0	0	3.6	2.9	2.6	3.9	5	6.3	7.6

Growth Rates

#	1 Year	3 Year	5 Year	10 Year
Sales CAGR	15%	18%	16%	14%
Operating Profit CAGR	20%	17%	13%	13%
PAT CAGR	26%	34%	12%	16%

#	1 Year	3 Year	5 Year	10 Year
Share Price CAGR	95%	23%	16%	NA%
ROE Average	8%	6%	5%	12%
ROCE Average	11%	9%	8%	14%

Shalby Balance Sheet

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Shareholder's Funds	102	141	168	205	251	751	780	799	835	876	928
Minority's Interest	4	3	2	0	-1	0	0	0	0	-0	-0
Borrowings	0	23	74	201	285	75	57	49	36	87	67
Other Non-Current Liabilities	10	10	16	6	5	65	73	96	115	146	202
Total Current Liabilities	36	40	90	92	199	138	88	83	82	172	194
Total Liabilities	152	217	351	504	741	1030	998	1027	1066	1282	1391
Fixed Assets	117	130	175	319	323	650	692	672	660	675	685
Other Non-Current Assets	8	23	114	120	259	144	109	121	136	158	189
Total Current Assets	27	63	63	64	159	236	197	234	271	442	517
Total Assets	152	217	351	504	741	1030	998	1027	1066	1282	1391

Shalby Cash Flow

#(Fig in Cr.)	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Opening Cash & Cash Equivalents	2	2	6	27	9	12	12	5	8	6	56
Cash Flow from Operating Activities	95	5	123	5	60	14	43	55	79	19	68
Cash Flow from Investing Activities	-9	-26	-62	-98	-153	-237	1	-31	-51	-60	-61
Cash Flow from Financing Activities	-86	24	-39	75	96	222	-51	-21	-30	90	-50
Net Cash Inflow / Outflow	0	3	22	-19	3	-0	-6	3	-2	49	-43
Closing Cash & Cash Equivalent	2	6	27	9	12	12	5	8	6	56	12

Shalby Ratios

#	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023
Earnings Per Share (Rs)	0	0	0	0	0	3.65	2.93	2.55	3.93	5.01	6.31
CEPS(Rs)	4.84	5.58	5.24	5.45	5.19	5.74	6	5.89	7.33	8.97	10.79
DPS(Rs)	0	0	0	0	0	0	0.5	0.5	1	1	1.2
Book NAV/Share(Rs)	0	0	0	0	0	69.57	72.2	74	77.28	81.13	86.37
Core EBITDA Margin(%)	18.49	24.24	24.53	19.13	22.08	20.88	18.06	17	20.27	17.39	17.17
EBIT Margin(%)	8.51	21.06	17.62	15.97	19.01	17.49	12.89	13.17	13.83	12.4	13.99
Pre Tax Margin(%)	8.31	20.14	15.63	12.37	15.6	14.21	10.9	11.65	12.78	11.32	12.68
PAT Margin (%)	6.67	14.58	8.91	12.51	8.87	10.36	6.85	5.67	9.83	7.72	8.41
Cash Profit Margin (%)	18.74	18.83	16.63	16.41	14.02	16.41	14.02	13.06	18.37	13.86	14.38
ROA(%)	9.88	20.47	8.64	8.49	4.61	4.42	3.12	2.72	4.05	4.6	5.06
ROE(%)	14.79	31.21	15.92	19.5	12.6	7.81	4.13	3.49	5.19	6.31	7.51
ROCE(%)	17.84	38.23	21.84	13.34	12.21	9.15	6.94	7.49	6.85	9.08	10.72
Receivable days	18.75	18.72	24.21	33.29	36.67	40.8	52.21	66.06	80.28	51.09	47.01
Inventory Days	9.9	8.87	8.15	8.37	8.53	9.51	9.82	10.51	16.21	37.64	69.5
Payable days	1671.42	1859.28	3358.6	4430.53	433.29	415.03	489.09	401.5	619.39	761.23	492.96
PER(x)	0	0	0	0	0	56.05	44.09	18.13	25.69	23.31	21.33
Price/Book(x)	0	0	0	0	0	2.94	1.79	0.63	1.31	1.44	1.56
Dividend Yield(%)	0	0	0	0	0	0	0.39	1.08	0.99	0.86	0.89
EV/Net Sales(x)	0.16	0.23	0.37	1.02	1.23	5.83	3.12	1.1	2.44	1.87	1.96
EV/Core EBITDA(x)	0.76	0.92	1.47	5.12	5.11	24.79	15.54	5.33	10.89	9.75	9.79
Net Sales Growth(%)	0	15	6.39	5.44	11.49	16.75	22.29	5.32	-11.49	62.21	15.16
EBIT Growth(%)	0	184.73	-10.99	-4.43	32.68	7.41	-9.88	7.68	-7.08	45.45	29.91
PAT Growth(%)	0	151.5	-34.96	47.93	-20.97	36.47	-19.19	-12.85	53.56	27.4	25.4
EPS Growth(%)	0	0	0	0	0	0	-19.6	-12.86	53.67	27.66	25.9
Debt/Equity(x)	0.05	0.26	0.58	1.09	1.31	0.15	0.09	0.08	0.05	0.18	0.15
Current Ratio(x)	0.75	1.56	0.69	0.7	0.8	1.7	2.23	2.81	3.32	2.56	2.66
Quick Ratio(x)	0.68	1.43	0.63	0.62	0.76	1.62	2.09	2.62	3.03	1.86	1.71
Interest Cover(x)	42.55	22.95	8.83	4.44	5.58	5.34	6.49	8.66	13.13	11.51	10.66
Total Debt/Mcap(x)	0	0	0	0	0	0.05	0.05	0.12	0.04	0.12	0.1

Shalby Shareholding Pattern

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	74.02	74.02	74.04	74.04	74.12	74.12	74.12	74.12	74.12	74.24
FII	3.83	3.95	3.92	3.78	3.97	3.91	4	4.11	4.62	4.88
DII	0	0	0	0.28	0.06	0	0	0	0	0
Public	22.15	22.03	22.04	21.9	21.85	21.96	21.88	21.77	21.26	20.89
Others	0	0	0	0	0	0	0	0	0	0
Total	100	100	100	100	100	100	100	100	100	100

#	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoter	7.99	7.99	8	8	8.01	8.01	8.01	8.01	8.01	8.02
FII	0.41	0.43	0.42	0.41	0.43	0.42	0.43	0.44	0.5	0.53
DII	0	0	0	0.03	0.01	0	0	0	0	0
Public	2.39	2.38	2.38	2.37	2.36	2.37	2.36	2.35	2.3	2.26
Others	0	0	0	0	0	0	0	0	0	0
Total	10.8	10.8	10.8	10.8	10.8	10.8	10.8	10.8	10.8	10.8

Pros

Debtor days have improved from 761.23 to 492.96days.
Company has reduced debt.
Company is almost debt free.

Cons

Company has a low return on equity of 6% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Shalby News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

Current Price: 135/-

Lakeshore Hospital

IPO

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Companies	Open Date	Close Date	Issue Price	Cost of 1 Lot	GMP	Expected Listing	Listing Gain(%)	Listing Price	Current Price	Type	Exchange

Shalby

Add Watchlist

Shalby Research see more...

Overview Inc. Year: 2004Industry: Hospital & Healthcare Services

Shalby Share Price

Alert Data

Quarterly Price

Peer Comparison

Shalby Quarterly Results

Shalby Profit & Loss

Growth Rates

Shalby Balance Sheet

Shalby Cash Flow

Shalby Ratios

Shalby Shareholding Pattern

Shalby News

Top Unlisted Companies & InstaBuy Companies

Lakeshore Hospital

IPO

Stocx: India's #1 Marketplace to Find Your Winning Stock

Please Login!

Error!